Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

More articles from Journal club

  • Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial
    Andrew W. Creamer, Shaney L. Barratt
    Breathe Jun 2019, 15 (2) 140-143; DOI: 10.1183/20734735.0002-2019
  • Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
    Guillermo Suarez-Cuartin, Maria Molina-Molina
    Breathe Jun 2019, 15 (2) 144-146; DOI: 10.1183/20734735.0016-2019
  • Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?
    Lydia J. Finney
    Breathe Jun 2019, 15 (2) 137-139; DOI: 10.1183/20734735.0015-2019
  • Low-dose computed tomography instead of radiography in suspected pneumonia
    Firdaus Mohamed Hoesein
    Breathe Mar 2019, 15 (1) 81-83; DOI: 10.1183/20734735.0319-2018
  • Was the implementation strategy of the ProACT trial adequately proactive?
    Alexander G. Mathioudakis, Jørgen Vestbo
    Breathe Mar 2019, 15 (1) 77-80; DOI: 10.1183/20734735.0338-2018
  • Assessing ethical climates in critical care and their impact on patient outcomes
    Emmanuel Okenyi, Thomas Michael Donaldson, Andrea Collins, Ben Morton, Angela Obasi
    Breathe Mar 2019, 15 (1) 84-87; DOI: 10.1183/20734735.0335-2018
  • The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD
    Claudia C. Dobler
    Breathe Dec 2018, 14 (4) 333-335; DOI: 10.1183/20734735.026418
  • Amazing pleiotropic effects of azithromycin
    Lies Lahousse
    Breathe Dec 2018, 14 (4) 336-337; DOI: 10.1183/20734735.025118
  • Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer
    Clementine Bostantzoglou, Marianthi Iliopoulou, Georgia Hardavella
    Breathe Dec 2018, 14 (4) 342-344; DOI: 10.1183/20734735.027118
  • Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
    Gabriella Long, Jasmine Wall
    Breathe Dec 2018, 14 (4) 338-341; DOI: 10.1183/20734735.026318

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society